| Market Cap | 4.55B 4.12B 3.81B 3.44B 6.48B 429B 6.71B 45.81B 18.17B 229B 17.07B 16.71B 727B | P/E 2024 |
-51.1x | P/E 2025 | -162x |
|---|---|---|---|---|---|
| Enterprise Value | 4.7B 4.26B 3.94B 3.55B 6.7B 443B 6.93B 47.31B 18.76B 237B 17.63B 17.26B 751B | EV / Sales 2024 |
5.69x | EV / Sales 2025 | 7.18x |
| Free-Float |
99.31% | Yield 2024 * |
-
| Yield 2025 | - |
Last Transcript: Amicus Therapeutics
| 1 day | +1.57% |
| Manager | Title | Age | Since |
|---|---|---|---|
George Davis
PSD | President | 55 | 2026-04-26 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +1.57% | +1.65% | - | - | 4.55B | ||
| -1.29% | -1.76% | +51.98% | +64.66% | 66.33B | ||
| -0.09% | +2.79% | +10.75% | +95.02% | 60.62B | ||
| +0.63% | +1.64% | +24.25% | +89.70% | 55.5B | ||
| -0.22% | -0.33% | +10.44% | +119.88% | 47.58B | ||
| -0.39% | -5.34% | +22.13% | +28.89% | 43.69B | ||
| -1.88% | -15.55% | +144.48% | +695.46% | 37.27B | ||
| +0.23% | +1.66% | +14.85% | +49.06% | 36.57B | ||
| +2.35% | -3.61% | +78.64% | +60.70% | 32.22B | ||
| +2.01% | +6.68% | -37.25% | +406.79% | 26.58B | ||
| Average | +0.33% | +0.33% | +35.59% | +178.91% | 45B | |
| Weighted average by Cap. | +0.02% | +0.33% | +35.39% | +153.74% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 528M 479M 443M 400M 753M 49.81B 779M 5.32B 2.11B 26.61B 1.98B 1.94B 84.46B | 634M 575M 532M 480M 904M 59.8B 936M 6.39B 2.53B 31.94B 2.38B 2.33B 101B |
| Net income | -56.11M -50.84M -47.03M -42.43M -79.96M -5.29B -82.78M -565M -224M -2.83B -211M -206M -8.97B | -27.11M -24.57M -22.72M -20.5M -38.64M -2.56B -40M -273M -108M -1.37B -102M -99.58M -4.33B |
| Net Debt | 194M 176M 162M 146M 276M 18.26B 286M 1.95B 773M 9.76B 727M 711M 30.97B | 149M 135M 125M 113M 212M 14.03B 220M 1.5B 594M 7.5B 559M 547M 23.79B |
Employees
-
















